Mario Negri Institute for Pharmacological Research

Institution (Nonprofit)

Homepage Wikipedia ROR

Also Known As

Instituto di Ricerche Farmacologiche Mario Negri, Mario Negri Institute for Pharmacological Research

19.9K

Publications

4.9M

Citations

2.3K

Authors

1.9K

Concepts

About

Mario Negri Institute for Pharmacological Research is a nonprofit institution in Milan, Italy known for medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	95	1.8K	225.6K
2	Engineering	80	1.6K	95.5K
3	Education	21	73	5.4K
4	Business	17	50	4.3K
5	Arts	6	13	575

Mario Negri Institute for Pharmacological Research

19.9K

Publications

4.9M

Citations

Page 1

	Year	Citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement David Moher, A. Liberati, Jennifer Tetzlaff, BMJ	2009	82.3K
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement David Moher, Alessandro Liberati, Jennifer Tetzlaff, PLoS Medicine Family MedicineCounselingSystematic Literature StudyEvidence-based MedicineAllied Health Professions	2009	61.5K
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. David Moher, Alessandro Liberati, Jennifer Tetzlaff, PubMed Family MedicineCounselingSystematic Literature StudyClinical GuidelinesPrimary Care	2009	45.1K
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement David Moher, Alessandro Liberati, Jennifer Tetzlaff, Journal of Clinical Epidemiology CounselingFamily MedicineSystematic Literature StudyMeta-analysisHealth Policy	2009	19.6K
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Rafael Lozano, Mohsen Naghavi, Kyle J Foreman, The Lancet	2012	14.1K
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement David Moher, Alessandro Liberati, Jennifer Tetzlaff, International Journal of Surgery	2010	11.5K
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Alessandro Liberati, Douglas G. Altman, Jennifer Tetzlaff, Journal of Clinical Epidemiology NursingNon-pharmacological InterventionPrimary CareEvidence-based InterventionMeta-analysis	2009	10.2K
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Christopher J L Murray, Theo Vos, Rafael Lozano, The Lancet Health SystemsGlobal BurdenEpidemiological TrendHealth EconomicsEpidemiological Outcome	2012	8.9K
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos, Abraham D Flaxman, Mohsen Naghavi, The Lancet Global BurdenDisease ManagementDisease ProgressionGlobal HealthSystematic Analysis	2012	8.3K
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, New England Journal of Medicine	2001	7.4K

Page 1